Insight Molecular Diagnostics Inc.

IMDX

Insight Molecular Diagnostics Inc.

IMDX

Insider Sentiment (TTM):

Last Purchase:2026-04-27Last Sale:-Shares Purchased (TTM):813,352Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:18,685,797Shares Outstanding:34,519,000Institutional Ownership Pct.:54.13%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	18	28	12	19	24	31	9	3	9	6	9	14
Accounts Receivable Net Current	0	0	1	0	1	4	2	0	0	0	0	1
Equity Securities Fv Ni	-	-	-	-	-	-	-	-	-	-	-	0
Assets Current
Assets Current	21	31	15	21	27	36	12	5	10	7	11	17
Inventory Net	0	0	0	0	1	0	0	0	-	-	-	-
Deferred Finance Costs Net	-	-	0	-	-	-	0	0	-	-	-	-
Restricted Cash Current	1	1	1	1	-	-	0	-	-	-	-	-
Prepaid Expense And Other Assets Current	2	1	1	1	1	1	1	1	1	1	1	1
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	0	-	-	-	0	0	0	0	0	0
Assets Noncurrent
Finance Lease Right Of Use Asset	-	-	-	2	3	3	3	3	3	2	2	2
Intangible Assets Net Excluding Goodwill	-	-	0	15	15	15	15	57	57	57	57	57
Restricted Cash Noncurrent	0	0	1	1	2	2	2	2	2	2	2	2
Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	0	0	1
Assets	29	40	26	44	51	60	35	70	75	71	75	82
Liabilities And Stockhold…
Accounts Payable Current	2	2	3	1	1	2	2	1	1	1	1	1
Other Liabilities Current	2	3	3	-	-	-	1	-	-	-	-	-
Accrued Liabilities Current	2	3	2	2	1	3	2	2	1	2	2	2
Accrued Royalties Current	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities Current
Accounts Payable And Other Accrued Liabilities Cur…	1	1	1	1	1	2	0	1	0	1	0	1
Liabilities Current	10	12	12	8	7	10	7	9	7	8	7	8
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	-	0	0
Business Combination Contingent Consideration Liab…	1	0	0	1	1	0	0	1	-	-	2	0
Liabilities Noncurrent
Business Combination Contingent Consideration Liab…	40	38	43	44	41	38	38	49	42	43	40	29
Liabilities	51	51	57	53	49	50	47	61	52	54	49	39
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	5	5	5
Preferred Stock Value	0	0	0	-	-	-	0	-	-	-	-	-
Common Stock Value	395	394	369	369	368	367	338	327	326	311	310	310
Stockholders Equity
Stockholders Equity	-21	-11	-31	-9	1	10	-12	10	23	12	20	36
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings Accumulated Deficit	-416	-405	-401	-378	-367	-357	-351	-317	-304	-299	-290	-262
Liabilities And Stockholders Equity	29	40	26	44	51	60	35	70	75	71	75	82
Allowance For Doubtful Accounts Receivable	-	-	-	-	-	-	-	-	-	0	0	0
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	0	0	0	-	-	0	-
Preferred Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	230	230	230	230	230	230	230	230	230	230	230	230
Common Stock Shares Issued	33	32	29	29	29	29	17	13	13	8	8	8
Shares Outstanding	33	32	29	29	29	29	17	13	13	8	8	8

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.75%	12.55%	-8.82%	-	-	-	-	-	-	-	-	-
2025	5.69%	1.42%	-8.90%	-4.98%	28.35%	130.27%	-22.94%	5.29%	-4.12%	-6.57%	55.96%	36.50%
2024	-7.12%	2.71%	0.00%	1.95%	-6.49%	-1.30%	-18.33%	-21.00%	-31.00%	-14.71%	-16.22%	-20.42%
2023	-	-	-	-	-	-	43.81%	-7.34%	16.01%	5.09%	-0.36%	10.18%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.00	2.54	1.27	2.79	4.04	3.75	1.62	0.53	1.38	0.78	1.49	2.11
Quick Ratio	1.82	2.42	1.11	2.57	3.73	3.57	1.45	0.43	1.30	0.70	1.40	2.02
Working Capital	10.26M	18.51M	3.23M	13.73M	20.19M	26.58M	4.48M	-4.30M	2.77M	-1.79M	3.50M	8.88M
Leverage & Debt
Debt to Equity	-2.38	-4.78	-1.82	-5.78	45.01	4.91	-3.86	6.23	2.29	4.66	2.41	1.08
Interest Coverage TTM	-513.24	-473.18	-469.03	-542.62	-554.63	-597.68	-726.68	-650.64	-731.82	-718.80	-483.38	-361.49
Debt Ratio	1.72	1.26	2.22	1.21	0.98	0.83	1.35	0.86	0.70	0.76	0.66	0.48
Efficiency & Turnover
Asset Turnover TTM	0.04	0.04	0.13	0.08	0.07	0.06	0.03	0.01	0.01	0.02	0.02	0.01
Days Sales Outstanding TTM	76.93	346.18	123.36	19.36	25.59	175.76	203.46	206.44	120.95	99.57	303.07	322.21
Receivables Turnover TTM	4.74	1.05	2.96	18.85	14.26	2.08	1.79	1.77	3.02	3.67	1.20	1.13
Per Share Metrics
Diluted EPS TTM	-1.34	-1.39	-1.65	-1.90	-1.98	-2.27	-4.66	-2.93	-2.59	-4.49	-3.63	-7.32
Free Cash Flow Per Share TTM	-0.84	-0.80	-0.83	-0.75	-0.74	-0.91	-1.62	-1.48	-1.44	-2.32	-3.09	-3.56
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	48.32%	50.69%	56.67%	54.45%	54.22%	52.56%	39.34%	3.95%	22.09%	32.42%	27.48%	34.38%
Operating Profit Margin TTM	-3,011.86%	-2,500.67%	-1,260.76%	-1,392.91%	-1,498.31%	-1,524.15%	-3,245.14%	-6,148.52%	-3,576.83%	-2,912.66%	-1,672.39%	-1,408.41%
Net Profit Margin TTM	-2,955.63%	-2,454.64%	-1,238.52%	-1,380.69%	-1,489.71%	-1,516.06%	-3,239.02%	-5,666.91%	-3,262.21%	-2,685.85%	-1,848.37%	-4,131.48%
Growth Metrics
Net Revenue Growth (1Y)	-60.77%	-49.28%	115.58%	520.87%	316.13%	178.08%	25.15%	-51.54%	-7.08%	57.94%	56.89%	-216.48%
Net Income Growth (1Y)	-22.17%	-17.89%	-17.57%	51.27%	90.03%	56.96%	119.31%	-33.53%	-47.10%	-41.20%	-62.16%	-5.38%
EPS Growth (1Y)	-32.18%	-38.88%	-64.65%	-35.24%	-23.63%	-49.52%	28.37%	-59.98%	-66.75%	-57.61%	-72.60%	-32.03%
Valuation Metrics
P/E TTM	-4.39	-2.37	-4.55	-1.75	-1.52	-1.35	-0.51	-0.97	-1.14	-0.65	-0.69	-0.43
P/B TTM	-10.18	-10.59	-7.26	-11.56	88.08	7.69	-2.53	4.02	1.67	2.09	0.93	0.71
P/S TTM	129.84	58.09	56.37	24.16	22.72	20.46	16.54	55.13	37.11	17.52	12.73	17.61
Market Cap	216.83M	113.22M	228.57M	106.35M	96.71M	78.62M	31.11M	39.08M	37.97M	24.21M	19.13M	25.76M
Enterprise Value	199.07M	85.02M	216.99M	87.66M	72.42M	47.59M	22.47M	35.72M	28.71M	18.64M	9.70M	11.98M
Calculated Values
Free Cash Flow TTM	-31.00M	-27.48M	-25.37M	-23.91M	-23.85M	-23.50M	-21.21M	-20.33M	-18.50M	-19.16M	-23.61M	-29.37M
Net Debt	-17.76M	-28.20M	-11.58M	-18.69M	-24.29M	-31.03M	-8.64M	-3.36M	-9.26M	-5.58M	-9.43M	-13.78M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-27Purchase

Owner: Broadwood, Partners, L.P.…

Title: -

Shares: 250,923

Price/Share: $3.64

Value: $913,359.72

Shares Owned: 12,684,884

Relationship: TenPercentOwner

Ownership: Direct

2026-04-20Purchase

Owner: Broadwood, Capital Inc, B…

Title: -

Shares: 40,690

Price/Share: $3.88

Value: $157,877.20

Shares Owned: 12,114,700

Relationship: TenPercentOwner

Ownership: Direct

2026-02-10Purchase

Owner: Bradsher, Neal C, Broadwo…

Title: -

Shares: 521,739

Price/Share: $5.75

Value: $2,999,999.25

Shares Owned: 11,931,839

Relationship: TenPercentOwner

Ownership: Direct

2025-02-07Purchase

Owner: Smith, Patrick W

Title: -

Shares: 1,077,600

Price/Share: $2.05

Value: $2,209,080.00

Shares Owned: 2,872,671

Relationship: TenPercentOwner

Ownership: Indirect

2025-02-07Purchase

Owner: James, Andrea S.

Title: Chief Financial Officer

Shares: 97,561

Price/Share: $2.05

Value: $200,000.05

Shares Owned: 151,231

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-27	Broadwood, Partners, L.P.…	TenPercentOwner	-	Direct	Purchase	250,923	3.64	$913,359.72	12,684,884	4
2026-04-20	Broadwood, Capital Inc, B…	TenPercentOwner	-	Direct	Purchase	40,690	3.88	$157,877.20	12,114,700	4
2026-02-10	Bradsher, Neal C, Broadwo…	TenPercentOwner	-	Direct	Purchase	521,739	5.75	$2,999,999.25	11,931,839	4
2025-02-07	Smith, Patrick W	TenPercentOwner	-	Indirect	Purchase	1,077,600	2.05	$2,209,080.00	2,872,671	4
2025-02-07	James, Andrea S.	Officer	Chief Financial Officer	Direct	Purchase	97,561	2.05	$200,000.05	151,231	4
2025-02-06	Broadwood, Partners, L.P.…	TenPercentOwner	-	Direct	Purchase	5,165,695	2.05	$10,589,674.75	11,410,100	4
2025-02-04	Smith, Patrick W	TenPercentOwner	-	Indirect	Purchase	25	2.02	$50.50	1,795,071	4
2025-01-30	Smith, Patrick W	TenPercentOwner	-	Indirect	Purchase	318	2.01	$639.18	1,794,156	4
2025-01-14	Smith, Patrick W	TenPercentOwner	-	Indirect	Purchase	10,386	2.12	$22,018.32	1,789,958	4
2024-12-26	Arno, Andrew	Director	-	Direct	Purchase	12,500	2.11	$26,375.00	81,554	4
2024-12-26	Smith, Patrick W	TenPercentOwner	-	Indirect	Purchase	90,219	2.13	$192,166.47	1,773,903	4
2024-12-05	James, Andrea S.	Officer	Chief Financial Officer	Direct	Purchase	20,000	2.29	$45,800.00	53,670	4
2024-10-02	Broadwood, Capital Inc, B…	TenPercentOwner	-	Direct	Purchase	1,315,339	2.95	$3,880,250.05	6,244,405	4
2024-10-02	James, Andrea S.	Officer	Chief Financial Officer	Direct	Purchase	33,670	2.97	$99,999.90	33,670	4
2024-04-11	Broadwood, Partners, L.P.…	TenPercentOwner	-	Direct	Purchase	2,420,000	2.92	$7,066,400.00	4,929,066	4
2024-04-11	Arno, Andrew	Director	-	Direct	Purchase	33,898	2.95	$99,999.10	69,054	4
2024-04-11	Riggs, Josh	Director,Officer	CEO and President	Direct	Purchase	3,390	2.95	$10,000.50	3,505	4
2023-06-14	Kingsley, Alfred D	Director	-	Direct	Purchase	30,000	0.21	$6,300.00	469,111	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

54.13%

Inst. Shares: 18,685,797

Shares Outstanding: 34,519,000

2025-12-31

54.51%

Inst. Shares: 16,611,057

Shares Outstanding: 30,476,000

2025-09-30

50.67%

Inst. Shares: 16,229,807

Shares Outstanding: 32,033,000

2025-06-30

47.60%

Inst. Shares: 15,242,668

Shares Outstanding: 32,023,000

2025-03-31

62.20%

Inst. Shares: 15,981,993

Shares Outstanding: 25,694,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	18,685,797	34,519,000	54.13%
2025-12-31	16,611,057	30,476,000	54.51%
2025-09-30	16,229,807	32,033,000	50.67%
2025-06-30	15,242,668	32,023,000	47.60%
2025-03-31	15,981,993	25,694,000	62.20%
2024-12-31	8,266,372	13,071,000	63.24%
2024-09-30	7,064,213	13,714,000	51.51%
2024-06-30	5,966,625	12,870,000	46.36%
2024-03-31	3,546,859	8,264,000	42.92%
2023-12-31	3,611,612	7,651,000	47.20%
2023-09-30	3,706,631	8,256,000	44.90%
2023-06-30	4,578,342	8,090,000	56.59%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Insight Molecular Diagnostics Inc. (IMDX) — SEC Financial Statements & Analysis

Insight Molecular Diagnostics Inc. (IMDX) is a in vitro & in vivo diagnostic substances company, incorporated in CA. Insight Molecular Diagnostics Inc. trades on Nasdaq as: IMDX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Insight Molecular Diagnostics Inc. reported a -60.77% year-over-year revenue growth, a Gross Profit Margin of 48.32% (TTM), a Debt-to-Equity ratio of -2.38x, a Price-to-Sales (P/S) ratio of 129.84x (TTM), a Price-to-Book (P/B) ratio of -10.18x (TTM), at a market cap of $216.83M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -60.77%
Gross Profit Margin TTM: 48.32%
Debt To Equity: -2.38x
P/S TTM: 129.84x
P/B TTM: -10.18x
Market Cap: $216.83M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Insight Molecular Diagnostics Inc. in?

Insight Molecular Diagnostics Inc. (IMDX) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is IMDX's market cap?

Insight Molecular Diagnostics Inc. (IMDX) has a market capitalization of $216.83M as of 2026-06-30.

What exchange does IMDX trade on?

Insight Molecular Diagnostics Inc. (IMDX) trades on the Nasdaq.

Where is Insight Molecular Diagnostics Inc. incorporated?

Insight Molecular Diagnostics Inc. is incorporated in CA.